20138 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate Encapsulating processes; Filling of capsules
COMPOSITION FOR TREATMENT OR REDUCTION OF SYMPTOMS RELATED TO PREMENSTRUAL SYNDROME (PMS), PREMENSTRUAL DISPHORIC DISORDER (PMDD), PREMENOPAUSE, MENOPAUSE OR FEMALE HORMONAL DISORDERS, IN A PHARMACEUTICAL COMPOSITION CONTAINING SAID FORM, AND PROCESS FOR PRODUCING SAID PHARMACEUTICAL FORM AND USE OF SAID COMPOSITION
#602Rotary die system
#603Edible oils to enhance delivery of orally administered steroids
#604SOLID PHARMACEUTICAL COMPOSITION COMPRISING AN ANTIBIOTIC FROM THE QUINOLONE FAMILY AND METHOD OF PRODUCTION THEREOF
#605RELEASE CAPSULES, MANUFACTURE AND USES THEREOF
#606Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases
#607Formulation for the controlled release of one or several substances in the digestive tract of a mammal
#608Pharmaceutical composition comprising nanocrystals
#609Methods and devices for forming treatment agent carriers
#610Gastroretentive dosage system and process of preparation thereof
#611Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates
#612Manufacture of peanut formulations for oral desensitization
#613Injection-molded dosage form
#614Apparatus and method for producing controlled dosage of bioactive agent
#615Coated controlled release active agent carriers
#616Seamless capsule and manufacturing method therefor
#617Crystal entecavir, crystal entecavir formulation and methods for the preparation thereof
#618Pharmaceutical compositions comprising an aromatse inhibitors
#619Multi-phase, multi-compartment, capsular delivery apparatus and methods for using same
#620MULTIPARTICULATE EXTENDED-RELEASE COMPOSITION OF MESALAMINE
#621SOFT CAPSULE PREPARATION, COMPOSITION FOR SOFT CAPSULE PREPARATION, AND METHOD OF PRODUCING SOFT CAPSULE PREPARATION
#622Solid naproxen concentrates and related dosage forms
#623Oral dosage forms of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide
#624Gastric reflux resistant dosage forms
#625Hybrid fragrance encapsulate formulation and method for using the same
#626Series of capsules comprising at least one drop of internal phase in a drop of intermediate phase and manufacturing method thereof
#627Formulation and manufacturing process for calcium acetate capsules
#628Bulk enteric capsule shells
#629AMPHIPHILIC CYCLIC PHOSPHAZENE TRIMER, PHARMACEUTICAL FORMULATION OF HYDROPHOBIC DRUGS BY MICELLE-ENCAPSULATION USING THE AMPHIPHILIC CYCLIC PHOSPHAZENE TRIMER, AND PREPARATION METHODS THEREOF
#630ENCAPSULATION OF HEAT AND MOISTURE SENSITIVE SUBSTANCES
#631Soft capsule based on starch and a method and device for the production thereof
#632Ingestible circuitry
#633Method for formulating large diameter synthetic membrane vesicles
#634Method for formulating large diameter synthetic membrane vesicles
#635Method for formulating large diameter synthetic membrane vesicles
#636Method for formulating large diameter synthetic membrane vesicles
#637METHOD FOR FORMULATING LARGE DIAMETER SYNTHETIC MEMBRANE VESICLES
#638Method for formulating large diameter synthetic membrane vesicles
#639Method for formulating large diameter synthetic membrane vesicles
#640METHOD FOR FORMULATING LARGE DIAMETER SYNTHETIC MEMBRANE VESICLES
#641METHOD FOR FORMULATING LARGE DIAMETER SYNTHETIC MEMBRANE VESICLES
#642Single use system for sterilely producing lipid-nucleic acid particles
#643SOLID NAPROXEN CONCENTRATES AND RELATED DOSAGE FORMS
#644soft capsule for reducing fat and losing weight and preparation method thereof
#645METHOD OF PRODUCING A HYDROGEL
#646Oral delivery for hemoglobin based oxygen carriers
#647PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#648Apixaban formulations
#649Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
#650Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone
#651Acid resistant capsules
#652ORGANIC COMPOUNDS
#653ENCAPSULATION OF REACTIVE COMPONENTS FOR 1-K SYSTEMS USING COAXIAL DIES
#654Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene
#655Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles
#656Solubilized CoQ-10
#657Integrated ingestible event marker system with pharmaceutical product
#658Pharmaceutical formulation containing gelling agent
#659Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
#660Anti-inflammatory agents
#661Apparatus and process for encapsulating microparticles with liquid in soft gel capsules
#662Apparatus and process for encapsulating capsules or other solid dosage forms within capsules
#663Apparatus and process for making soft gel capsules
#664Starch foils and/or films and a method and use of a device for the production thereof
#665Method for manufacturing capsule series, and related capsule series
#666Soft capsule based on starch and a method and device for the production thereof
#667METHOD FOR FORMULATING LARGE DIAMETER SYNTHETIC MEMBRANE VESICLES
#668OXYCODONE HYDROCHLORIDE HAVING LESS THAN 25 PPM 14-HYDROXYCODEINONE
#669Ingestible circuitry
#670High strength seamless alginate capsules
#671Seamless alginate capsules
#672SOLID NAPROXEN CONCENTRATES AND RELATED DOSAGE FORMS
#673PROCESS FOR OBTAINING POWDER COMPOSITIONS OF ORLISTAT
#674CONTINUOUS PROCESS FOR MAKING PHARMACEUTICAL COMPOSITIONS
#675ORAL PHARMACEUTICAL PARICALCITOL FORMULATIONS
#676Solid pharmaceutical compositions and processes for their production
#677Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitor
#678Identifier circuits for generating unique identifiable indicators and techniques for producing same
#679Method and apparatus for in situ drug delivery during distraction osteogenesis
#680HOT MELT-FILLED SOFT CAPSULES
#681Physically/molecularly distributed and/or chemically bound medicaments in empty, hard capsule shells
#682Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same
#683Multi-phase, multi-compartment, capsular delivery apparatus and methods for using the same
#684ENCAPSULATED MESENCHYMAL STEM CELLS AND USES THEREOF
#685Pharmaceutical compositions resistant to abuse
#686Hydroxypropyl Methyl Cellulose Hard Capsules and Process of Manufacture
#687Pharmaceutical formulation containing gelling agent
#688BLOW-MOLDED THIN-WALLED DRUG DELIVERY CAPSULES
#689Gastric reflux resistant dosage forms
#6908a,14-dihydroxy-7,8-dihydrocodeinone
#691MULTI PORTION INTRA-ORAL DOSAGE FORM AND USE THEREOF
#692Delivery of a bioactive material
#693SEAMLESS CAPSULE
#694ENCAPSULATED PICOPLATIN
#695ENCAPSULATION OF HEAT AND MOISTURE SENSITIVE SUBSTANCES
#696ORGANIC COMPOUNDS
#697Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
#698Gellan Seamless Breakable Capsule and Process for Manufacturing Thereof
#699Chewable capsule and production method thereof
#700Abuse Resistant Capsules
#701Pharmaceutical composition containing gelling agent
#702Ibuprofen-Hydrocodone-Antihistamine Composition
#703Emetic embedded capsule
#704Methods and devices for forming treatment agent carriers
#705Solid form
#706Pharmaceutical Formulations
#707Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone
#708METHOD AND APPARATUS FOR BLOWMODING CAPSULES OF POLYVINYLALCOHOL AND BLOWMOLDED POLYVINYLALCOHOL CAPSULES
#709Seamless capsule containing water-soluble active substance
#710Gastric reflux resistant dosage forms
#711Formulation and manufacturing process for calcium acetate capsules
#712Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
#713Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
#714Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
#715STABLE PHARMACEUTICAL COMPOSITIONS
#716ENTERIC VALPROIC ACID
#717Enteric valproic acid
#718Methods and apparatus for sealing capsules
#719Solvent system for enhancing the solubility of pharmaceutical agents
#720Masticatable capsule and process for producing the same
#721Seamless capsule
#722Oxycodone hydrochloride having less than 25 ppm 14- hydroxycodeinone
#723Probiotic and preservative uses of oil-emulsified probiotic encapsulations
#724System and process for providing at least one opening in dosage forms
#725Process for producing aspheric seamless capsule and apparatus therefor
#726Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene
#727Pharmaceutical compositions with synchronized solubilizer release
#728Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
#729Pharmaceutical formulations
#730Dietary supplement and method of processing same
#731Seamless filled capsules
#732Solubilized CoQ-10
#733Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
#734Oral brexanolone compositions and methods of preparation and use
#735Dosage forms of mirdametinib
#736Concentrated nutritional or supplemental compound for intestinal, gut-brain axis and neurobiological homeostasis through calibrated absorption including neurotransmitter or any equilibrating compound release to treat or mitigate disease and co-morbidities, particularly obesity and malnourishment
#737Treatment of post-operative pain via sciatic nerve block with sustained-release liposomal anesthetic compositions
#738Method and system for reducing active ingredient potency in pain-management compositions to a quarter amount of approved levels
#739Vaginal probiotic products and related processes
#740Vaginal probiotic products and related processes
#741Delayed-release encapsulation of deer velvet powder to protect the deer velvet powder until micellization and absorption within the terminal illium
#742Process for manufacturing pullulan hard capsules having improved film properties
#743Vaginal probiotic products and related processes
#744Opioid abuse deterrent dosage forms
#745Process of making stable abuse-deterrent oral formulations